Trial intelligence / Profile preview

hUC-MSCs with Injectable Collagen Scaffold for Chronic Ischemic Cardiomyopathy

NCT02635464Phase 2Completed

Sponsor
Chinese Academy of Sciences
Start
Oct 2015
Primary completion
Aug 2019
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of human umbilical cord mesenchymal stem cells in ischemic cardiomyopathy (ICM), sponsored by Chinese Academy of Sciences. Started Oct 2015; status: completed.

02

Drugs

human umbilical cord mesenchymal stem cells
03

Conditions

ischemic cardiomyopathy (ICM)

Beyond the preview

Go deeper on NCT02635464.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02635464.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call